Bamifylline Hydrochloride

盐酸巴米茶碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBamifylline Hydrochloride
Drug Alias Name盐酸苄胺茶碱bamifylline巴美菲林盐酸盐bamifilinabamifyllinum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine receptor antagonists
TargetsAdenosine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasis
Inactive IndicationsN/A

Other Information

ATC CodeR03DA08
Related LinksWikipediaKEGG